Target intelligence / Profile preview

DNA cross-link repair 1C (DCLRE1C)

Target
DCLRE1C
Molecular classification
Enzyme, Endonuclease, DNA repair protein, Other
01

Overview

DNA cross-link repair 1C (DCLRE1C), also known as Artemis, is a nuclear enzyme essential for the repair of DNA double-strand breaks and for V(D)J recombination, a process critical for generating diverse antigen receptors on B and T lymphocytes. Artemis possesses endonuclease activity that processes DNA hairpins during immune receptor gene assembly, functioning in complex with the DNA-dependent protein kinase (DNA-PKcs). Mutations in DCLRE1C disrupt lymphocyte development and cause severe combined immunodeficiency (SCID), often associated with extreme sensitivity to ionizing radiation. Deficient individuals typically lack mature B and T lymphocytes and present with life-threatening infections, but milder antibody deficiency or variable immunodeficiency phenotypes are also documented.

Other names
ArtemisSCIDAA-SCIDFLJ11360SNM1CPSO2 homolog (S. cerevisiae)
02

Mechanism of action

For therapeutic targeting (gene therapy/transplant): restoration of functional DNA repair and V(D)J recombination in lymphoid cells; not classic small-molecule modulation

03

Biological functions

DNA repairV(D)J recombinationImmune responseDNA double-strand break processing
04

Disease associations

Severe combined immunodeficiency (SCID)Immunodeficiency disordersInflammationOther (may present as antibody deficiency or partial immunodeficiency)
05

Safety considerations

Susceptibility to severe infectionspoor immune reconstitution following hematopoietic stem cell transplantationincreased risk from ionizing radiation due to impaired DNA repairrisk of malignancy due to defective genome maintenance
06

Interacting drugs

None established as direct molecular inhibitors or activators; interventions primarily involve gene therapy or hematopoietic stem cell transplantation
07

Biomarkers

Severe lymphopeniaabsence or reduction of B and T cellsradiosensitivitydefective DNA repair on cellular assays

Beyond the preview

Go deeper on DNA cross-link repair 1C (DCLRE1C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA cross-link repair 1C (DCLRE1C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call